Prof. dr hab. Jan Styczyński, head of the Division of Clinical and Experimental Oncology at the Faculty of Medicine of NCU Collegium Medicum, has been elected as Vice-President of the European Conference on Infections in Leukaemia (ECIL).
Prof. dr hab. Jan Styczyński, head of the Division of Clinical and Experimental Oncology of the Department of Paediatrics, Haematology and Oncology at the Faculty of Medicine of NCU Collegium Medicum, has been elected as Vice-President of the European Conference on Infections in Leukaemia (ECIL) at the seventh ECIL meeting in Sophia-Antipolis.
ECIL is a non-profit scientific organisation registered in Belgium and established in 2005 by four European associations: the EORTC (European Organisation for Research and Treatment of Cancer) Infectious Diseases Group, the EBMT (European Society for Blood and Marrow Transplantation) Infectious Diseases Working Party, the ELN (European LeukemiaNet) Supportive Care Group, and the Immunocompromised Host Society.
Statutory activities of ECIL include: developing recommendations on the diagnosis, prevention and treatment of infectious complications in patients with leukaemia and other haematological cancers or undergoing haematopoietic stem cell transplantation; adopting current strategies for anti-infective patient management in haematology and haematopoietic stem cell transplantation; facilitating cooperation between individual working groups, as well as defining new directions for clinical research.
Participation in ECIL projects is only possible upon invitation by the Organisation Committee, which is granted to researchers with notable scientific achievements. ECIL has so far published 35 sets of recommendations for the management of infectious complications in haematology and haematopoietic stem cell transplantation.